Growth Metrics

KalVista Pharmaceuticals (KALV) Other Non-Current Liabilities (2024)

Historic Other Non-Current Liabilities for KalVista Pharmaceuticals (KALV) over the last 3 years, with Q4 2024 value amounting to $99.9 million.

  • KalVista Pharmaceuticals' Other Non-Current Liabilities changed N/A to $99.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $99.9 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2014, which is N/A changed from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Other Non-Current Liabilities stood at $99.9 million for Q4 2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Other Non-Current Liabilities peaked at $99.9 million during Q4 2024, and registered a low of $99.9 million during Q4 2024.